WebMD: Excerpt: The Washington state-based b
Post# of 148288
Excerpt:
The Washington state-based biotech firm CytoDyn is preparing a clinical trial that would combine remdesivir with leronlimab, a drug that inhibits viral infection and also has shown some anti-inflammatory effects, the company announced this week.
https://www.webmd.com/lung/news/20200521/comb...reatment#1